- Home
- GIGM vs COSM Comparison
GIGM vs COSM Comparison
Compare GIGM & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIGM | COSM |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8M | 15.4M |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GIGM | COSM |
|---|---|---|
| Price | $1.46 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.0K | ★ 697.2K |
| Earning Date | 10-30-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,397,000.00 | ★ $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.11 | 6.69 |
| 52 Week Low | $1.38 | $0.28 |
| 52 Week High | $1.89 | $1.32 |
Technical Indicators
Market Signals| Indicator | GIGM | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 44.68 |
| Support Level | $1.50 | $0.47 |
| Resistance Level | $1.56 | $0.59 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 13.33 | 65.79 |
Price Performance
Historical ComparisonAbout GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.